STOCK TITAN

Koninklijke Philips N.V. - PHG STOCK NEWS

Welcome to our dedicated news page for Koninklijke Philips N.V. (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Philips N.V..

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Koninklijke Philips N.V.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Koninklijke Philips N.V.'s position in the market.

Rhea-AI Summary
Royal Philips expands access to virtually helium-free MRI technology at #ECR2024, with over 1,000 systems installed worldwide. The innovative BlueSeal magnet requires minimal helium, easing installation and addressing helium scarcity, benefiting patients in diverse locations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
none
-
Rhea-AI Summary
Royal Philips proposes Charlotte Hanneman as new CFO, succeeding Abhijit Bhattacharya on October 1, 2024. Ms. Hanneman brings over 20 years of experience in MedTech and pharmaceutical industries, joining from Stryker. The proposal will be submitted to the AGM on May 7, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
none
-
Rhea-AI Summary
Royal Philips Launches Azurion Neuro Biplane System to Enhance Neurovascular Procedures and Stroke Treatment
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
none
Rhea-AI Summary
Philips focuses on improving ESG performance, aiming to improve 2 billion lives by 2025. The company enhanced circular revenues, reduced carbon emissions, and expanded eco-friendly products. Partnerships drive sustainable healthcare solutions and diversity initiatives. Philips excels in low-carbon operations and governance standards, ranking highly in sustainability indices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
none
-
News
Rhea-AI Summary
Royal Philips (PHG) releases its Annual Report 2023, to be discussed at the upcoming AGM on May 7, 2024. The report is filed in ESEF format and will soon be filed on Form 20-F with the SEC. Shareholders can access the report online or request a printed copy for free.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
none
-
Rhea-AI Summary
Royal Philips announces proposed re-appointments and new appointment to the Supervisory Board, including Exor N.V.'s nominee Benoît Ribadeau-Dumas, to support Philips' value creation strategy and purpose.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
none
Rhea-AI Summary
Royal Philips has received FDA 510(k) clearance for its latest IntelliVue patient monitor software, featuring new solutions including the Philips Sounds alarm package, aimed at creating a more peaceful and healing environment for patients and caregivers. The new software aims to reduce alarm noise by up to 66%, addressing the impact of alarm sounds on patients, families, and care providers. The changes are based on significant research investment and input from clinicians, sound experts, and patients in alarm-heavy environments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
none
-
Rhea-AI Summary
Royal Philips (PHG) has developed a smaller X11-4t Mini 3D TEE transducer to serve more patients with improved overall comfort, receiving FDA 510(k) clearance. The transducer aims to improve patient comfort, reduce the need for general anesthesia, and lower the risk of complications. Early clinical users have recognized its value, and it is compatible with Philips' premium cardiology ultrasound portfolio. The X11-4t is scheduled for commercial availability in 2024 and is pending CE mark in Europe.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.4%
Tags
none
-
Rhea-AI Summary
Philips delivers strong sales growth, improved profitability, and strong cash flow in 2023 through solid execution of the first year of the 2023-2025 plan. The company agreed with FDA on terms of a consent decree focused on Philips Respironics in the US, providing clarity and a roadmap to demonstrate compliance and restore the business. Despite challenges, Philips reiterates confidence in delivering the 2023-2025 plan and expects further performance improvement in 2024. Group sales amounted to EUR 18.2 billion in 2023, with a comparable sales growth of 7%. The company's income from operations was EUR -115 million in 2023, but increased to EUR 24 million in Q4. Adjusted EBITA margin increased to 10.5% of sales in 2023 and 12.5% in Q4. Free cash flow also increased to EUR 1,582 million in 2023 and EUR 1,128 million in Q4. The proposed dividend is maintained at EUR 0.85 per share, to be distributed in shares. Philips expects to deliver 3-5% comparable sales growth and an Adjusted EBITA margin of 11-11.5% in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.4%
Tags
none
Rhea-AI Summary
Royal Philips introduces the Philips Norelco OneBlade Intimate, a gender-neutral intimate trimmer and shaver designed to protect sensitive pubic and armpit skin. It is the first unisex tool in the Philips Norelco lineup, catering to anyone with intimate grooming needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none
Koninklijke Philips N.V.

NYSE:PHG

PHG Rankings

PHG Stock Data

18.65B
766.48M
7.75%
0.22%
Irradiation Apparatus Manufacturing
Manufacturing
Link
Netherlands
Amsterdam

About PHG

Koninklijke Philips N.V., commonly shortened to Philips, is a Dutch multinational conglomerate corporation that was founded in Eindhoven in 1891. Since 1997, it has been mostly headquartered in Amsterdam, though the Benelux headquarters is still in Eindhoven.